China Biotech Services (8037) Announces Completion of US$35.00 million Convertible Bond Issue and Adjustments to 2024 Convertible Bonds

Bulletin Express

Feb 23

China Biotech Services Holdings Limited (8037) completed the issuance of convertible bonds under a specific mandate in the aggregate principal amount of US$35.00 million on February 20, 2026. Upon full conversion of these bonds at the agreed conversion price, the total number of shares would increase from 975.73 million to approximately 1.39 billion, with the subscriber’s stake at 29.72%.

Prior to this issuance, there were outstanding 2024 convertible bonds amounting to US$6.00 million. Following completion of the new issuance on February 20, 2026, the conversion price of these 2024 convertible bonds was adjusted from HK$1.20 to HK$1.11 per share. As a result, the maximum number of shares issuable under full conversion of the 2024 convertible bonds rose to around 42.43 million shares. All other terms of the 2024 convertible bonds remain unchanged.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1122137683"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1122137683\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1122137683?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-23 08:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1122137683","market":"hk","top_or_hot":-1,"title":"China Biotech Services (8037) Announces Completion of US$35.00 million Convertible Bond Issue and Adjustments to 2024 Convertible Bonds","media":"Bulletin Express","content":"<p>China Biotech Services Holdings Limited (8037) completed the issuance of convertible bonds under a specific mandate in the aggregate principal amount of US$35.00 million on February 20, 2026. Upon full conversion of these bonds at the agreed conversion price, the total number of shares would increase from 975.73 million to approximately 1.39 billion, with the subscriber’s stake at 29.72%.</p>\n<p>Prior to this issuance, there were outstanding 2024 convertible bonds amounting to US$6.00 million. Following completion of the new issuance on February 20, 2026, the conversion price of these 2024 convertible bonds was adjusted from HK$1.20 to HK$1.11 per share. As a result, the maximum number of shares issuable under full conversion of the 2024 convertible bonds rose to around 42.43 million shares. All other terms of the 2024 convertible bonds remain unchanged.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Biotech Services (8037) Announces Completion of US$35.00 million Convertible Bond Issue and Adjustments to 2024 Convertible Bonds</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Biotech Services (8037) Announces Completion of US$35.00 million Convertible Bond Issue and Adjustments to 2024 Convertible Bonds\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-23 08:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Biotech Services Holdings Limited (8037) completed the issuance of convertible bonds under a specific mandate in the aggregate principal amount of US$35.00 million on February 20, 2026. Upon full conversion of these bonds at the agreed conversion price, the total number of shares would increase from 975.73 million to approximately 1.39 billion, with the subscriber’s stake at 29.72%.</p>\n<p>Prior to this issuance, there were outstanding 2024 convertible bonds amounting to US$6.00 million. Following completion of the new issuance on February 20, 2026, the conversion price of these 2024 convertible bonds was adjusted from HK$1.20 to HK$1.11 per share. As a result, the maximum number of shares issuable under full conversion of the 2024 convertible bonds rose to around 42.43 million shares. All other terms of the 2024 convertible bonds remain unchanged.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"08037","symbol_name":"中国生物科技服务","start_time":0,"source_url":"","article_id":"1122137683","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122137683","pubTimestamp":1771806171,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Biotech Services Holdings Limited (8037) completed the issuance of convertible bonds under a specific mandate in the aggregate principal amount of US$35.00 million on February 20, 2026. Upon...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"08037":"中国生物科技服务"},"translate_title":"中国生物科技服务(8037)公布完成3,500万美元可换股债券发行及调整2024年可换股债券","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"08037":1},"content_text":"China Biotech Services Holdings Limited (8037) completed the issuance of convertible bonds under a specific mandate in the aggregate principal amount of US$35.00 million on February 20, 2026. Upon full conversion of these bonds at the agreed conversion price, the total number of shares would increase from 975.73 million to approximately 1.39 billion, with the subscriber’s stake at 29.72%.\nPrior to this issuance, there were outstanding 2024 convertible bonds amounting to US$6.00 million. Following completion of the new issuance on February 20, 2026, the conversion price of these 2024 convertible bonds was adjusted from HK$1.20 to HK$1.11 per share. As a result, the maximum number of shares issuable under full conversion of the 2024 convertible bonds rose to around 42.43 million shares. All other terms of the 2024 convertible bonds remain unchanged.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}